INDV

アフターアワーズ： 28.78

Indivior Pharmaceuticals Inc (INDV)

概要ニュース株価時系列ディスカッション予測

Relative Volume:

ネットキャッシュフロー:

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Indivior Pharmaceuticals Inc

Healthcare (1119)

804-379-1090

10710 MIDLOTHIAN TURNPIKE, NORTH CHESTERFIELD

INDV's Discussions on Twitter

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
INDV Indivior Pharmaceuticals Inc	28.78	3.53B	1.24B	209.00M	-94.86M	1.6605
TAK Takeda Pharmaceutical Co Adr	18.27	56.58B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	116.33	47.85B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	10.00	43.75B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	28.35	33.47B	17.41B	1.43B	1.00B	1.2182
UTHR United Therapeutics Corp	588.36	22.91B	3.18B	1.33B	1.04B	27.90

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2025-08-06	開始されました	H.C. Wainwright	Buy
2025-07-22	再開されました	Jefferies	Buy
2025-01-28	開始されました	Rodman & Renshaw	Buy
2024-07-23	開始されました	Piper Sandler	Overweight
2024-04-03	開始されました	Craig Hallum	Buy
2023-07-13	開始されました	Northland Capital	Outperform

Indivior Pharmaceuticals Inc (INDV) 最新ニュース

Indivior Pharmaceuticals Inc (INDV) 財務データ

Indivior Pharmaceuticals Inc (INDV)

Indivior Pharmaceuticals Inc Stock (INDV) Company Profile

Compare INDV vs TAK, ZTS, HLN, TEVA, UTHR

Indivior Pharmaceuticals Inc Stock (INDV) Upgrades & Downgrades

Indivior Pharmaceuticals Inc (INDV) 最新ニュース

Indivior: Still Attractive After FY25 Earnings Beat (NASDAQ:INDV) - Seeking Alpha

Is It Time To Reassess Indivior Pharmaceuticals (INDV) After Its 200% One Year Surge? - simplywall.st

Hennion & Walsh Asset Management Inc. Purchases 96,177 Shares of Indivior PLC $INDV - MarketBeat

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B - MSN

If You Invested $1,000 in Indivior Pharmaceuticals Inc. (INDV) - Stock Titan

Indivior PLC (NASDAQ:INDV) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Levi & Korsinsky Reminds Indivior Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 1, 2024INDV - marketscreener.com

Indivior (INDV) posts 2025 growth, SUBLOCADE gains and $400M buyback in 2026 proxy - Stock Titan

Suboxone Market Size Forecasts 2026-2033: Analyzing Industry - openpr.com

Indivior PLC Stock Faces Uncertainty Amid U.S. Domicile Shift and OUD Market Focus - AD HOC NEWS

Indivior Pharmaceuticals Inc (INDV) Shares Up 5.07% on Mar 25 - GuruFocus

Indivior, Liquidia, Crinetics top Quant pharma list as Merck scoops up Terns for $6.7B (XLV:NYSEARCA) - Seeking Alpha

Down 12.9% Over the Past Month: Reasons to Consider Purchasing Indivior Pharmaceuticals Inc. (INDV) During the Decline - Bitget

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV) - Yahoo Finance

INDV Stock Price, Quote & Chart | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill

FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView

[SCHEDULE 13G] Indivior Pharmaceuticals, Inc. Passive Investment Disclosure (>5%) - Stock Titan

Indivior Pharmaceuticals to report Q4 earnings: What's in the cards? - MSN

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Recent Share Price Weakness - Sahm

Implied volatility surging for Indivior Pharmaceuticals stock options - MSN

Indivior Pharmaceuticals Inc (INDV) Shares Gap Down to $29.44 on Mar 20 - GuruFocus

Indivior (NASDAQ:INDV) Upgraded by Zacks Research to "Strong-Buy" Rating - MarketBeat

Goldentree Asset Management LP Makes New Investment in Indivior PLC $INDV - MarketBeat

Indivior outlines 30% adjusted EBITDA growth target for 2026 with new $400M share repurchase program - MSN

Indivior Issues $500 Million Convertible Senior Notes Offering - TipRanks

[Form 4] Indivior Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Indivior Pharmaceuticals Raises $500 Million Via 0.625% Convertible Notes Due 2031 - TradingView

Indivior Pharmaceuticals Survey Reveals Gaps in Medications for Opioid Use Disorder in U.S. Jails and Prisons - Quiver Quantitative

National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder - GlobeNewswire

Indivior plans $400M convertible senior notes offering - MSN

Indivior PLC $INDV Shares Acquired by Divisadero Street Capital Management LP - MarketBeat

Indivior plans $400 million convertible notes offering By Investing.com - Investing.com Nigeria

Does Indivior’s Upsized Convertible Notes and Buybacks Shift the Bull Case For Indivior (INDV)? - simplywall.st

How Indivior’s Upsized $450 Million Convertible Notes and Buybacks May Impact Indivior (INDV) Investors - Yahoo Finance

Melqart Asset Management UK Ltd Increases Position in Indivior PLC $INDV - MarketBeat

Indivior PLC $INDV is Mangrove Partners IM LLC's Largest Position - MarketBeat

Indivior director Kingsley buys $29,953 in shares By Investing.com - Investing.com Nigeria

Is It Too Late To Consider Indivior Pharmaceuticals (INDV) After A 221% One Year Surge? - simplywall.st

Indivior prices $450 million convertible notes offering By Investing.com - Investing.com Australia

Insider Buying: Barbara Ryan Acquires Shares of Indivior Pharmac - GuruFocus

INDV SEC FilingsIndivior Pharmaceuticals Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Indivior Pharmaceuticals prices upsized $450M convertible senior notes - MSN

Indivior PLC Stock (ISIN: US45580R1068) Drops 6% as $450M Convertible Notes Offering Signals Capital - AD HOC NEWS

Indivior (NASDAQ:INDV) Sees Strong Trading VolumeTime to Buy? - MarketBeat

Analysts Are Bullish on These Healthcare Stocks: Indivior (INDV), Gyre Therapeutics (GYRE) - The Globe and Mail

Indivior Prices Upsized Convertible Notes for Debt Refinancing - TipRanks

Indivior prices upsized $450M 0.625% convertible notes due 2031 - TradingView

Indivior (INDV) Upsizes Convertible Notes Offering to $450M - GuruFocus

Indivior Pharmaceuticals Inc (INDV) 財務データ

収益

当期純利益

現金流量

EPS

INDVに似た銘柄